dosing them on different days made no difference i could detect, thats just me
#cagrilintide 2026-02-03
- factory_direct_fi — genuine question went slower because the first step gave me two rough days and i took that as information, i could be wrong 21:35
- nausea_window — two PeptideMeter results on the same QYB lot came back 97.4 and 99.4, closer than i expected 22:05
- nausea_window — sorry to jump in held at 1 for 7 months on monotherapy before i touched it again 22:28
- nausea_window — weekly for me, same day every week, no reason beyond habit 22:30
- surpass_two — whats the recon people use, 5 in 2.5ml 23:05
genuine question went slower because the first step gave me two rough days and i took that as information, i could be wrong
is the slower titration because of nausea or something else
amylin not glp-1
monotherapy question, did appetite move for you without a GLP-1 alongside
2 in 0.5ml gives 2mg/ml which is what i use, purely because the units come out round
did anyone add this to an existing retatrutide dose rather than starting both
did the nausea feel different to you or just less
two PeptideMeter results on the same QYB lot came back 97.4 and 99.4, closer than i expected
monotherapy did work for me, just slower and smaller than i expected
follow up i keep the two on separate days so if something goes wrong i have a chance of knowing which
nobody should copy my schedule, im describing it because people asked what a slow ramp looks like
monotherapy was underwhelming for me and i say that as someone who wanted it to work, n of 1 obviously
sorry to jump in held at 1 for 7 months on monotherapy before i touched it again
weekly for me, same day every week, no reason beyond habit
is there a reason people titrate this over more weeks than the others
did anyone find monotherapy underwhelming
anyone holding at 7.5 for a while before stepping
whats the recon people use, 5 in 2.5ml
its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake
right so whats REDEFINE testing exactly
CagriSema is cagrilintide with semaglutide and REDEFINE is the trial programme around it